HEPATIC RESECTION is the treatment of choice for hepatic malignancy; however, this may be achieved in fewer than 30% of those with primary
1,2 and in 10% to 20% of those with secondary hepatic malignancies.
1,3,4 Hepatic resection may be contraindicated because of multifocal bilateral disease, tumor proximity to major vascular or biliary structures, technical inaccessibility of the tumor because of previous hepatectomy, or inadequate functional hepatic reserve related to coexistent cirrhosis. For these groups of patients, other techniques of therapy have been explored. In situ techniques for the destruction of tumors, such as cryosurgery and radiofrequency, are accepted as alternative therapies for those with unresectable hepatic malignancies.